Biology:Lecidella carpathica
From HandWiki
Short description: Species of lichen
| Lecidella carpathica | |
|---|---|
.jpg)
| |
Scientific classification 
| |
| Domain: | Eukaryota |
| Kingdom: | Fungi |
| Division: | Ascomycota |
| Class: | Lecanoromycetes |
| Order: | Lecanorales |
| Family: | Lecanoraceae |
| Genus: | Lecidella |
| Species: | L. carpathica
|
| Binomial name | |
| Lecidella carpathica Körb. (1861)
| |
| Synonyms[1] | |
|
List
| |
Lecidella carpathica is a species of crustose lichen in the family Lecanoraceae.[2] It was formally described as a new species in 1861 by the German lichenologist Gustav Wilhelm Körber.[3]
Three secondary metabolites that occur in this species, hopane-6α,22-diol, brialmontin, and atraric acid, inhibit the enzyme protein tyrosine phosphatase 1B. This enzyme is a therapeutic target for diabetes treatments and plays a major role in negative regulation of the insulin signaling pathway.[4]
References
- ↑ "Synonymy. Current Name: Lecidella carpathica Körb., Parerga lichenol. (Breslau) 3: 212 (1861) [1865"]. Species Fungorum. https://www.speciesfungorum.org/Names/SynSpecies.asp?RecordID=367785.
- ↑ "Lecidella carpathica Körb.". Species 2000: Naturalis, Leiden, the Netherlands. https://www.catalogueoflife.org/data/taxon/3SV7H.
- ↑ Körber, G.W. (1861) (in de). Parerga lichenologica. Ergänzungen zum Systema lichenum Germaniae. 3. pp. 193–288 [212].
- ↑ Seo, Changon; HanYim, Joung; Kum Lee, Hong; Oh, Hyuncheol (2011). "PTP1B inhibitory secondary metabolites from the Antarctic lichen Lecidella carpathica". Mycology 2 (1): 18–23. doi:10.1080/21501203.2011.554906.
Wikidata ☰ Q15016954 entry
 |  |
